131 related articles for article (PubMed ID: 8402717)
21. Chemically modified and recombinant hemoglobin blood substitutes.
Snyder SR; Walder JA
Biotechnology; 1991; 19():101-16. PubMed ID: 1786467
[TBL] [Abstract][Full Text] [Related]
22. [Purification and viral inactivation of hemoglobin from human placenta blood].
Li T; Zhang H; Wang H; Yu R; Yang C
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Jun; 23(3):640-4. PubMed ID: 16856406
[TBL] [Abstract][Full Text] [Related]
23. Comparison of Hemoglobin-based oxygen carriers to stored human red blood cells.
Eastman AL; Minei JP
Crit Care Clin; 2009 Apr; 25(2):303-10, Table of Contents. PubMed ID: 19341910
[TBL] [Abstract][Full Text] [Related]
24. Fake blood market gets hemoglobin transfusion from reticulocytes.
Glaser V
Nat Biotechnol; 1998 Aug; 16(8):709. PubMed ID: 9702757
[No Abstract] [Full Text] [Related]
25. Automated quantitation of hemoglobin-based blood substitutes in whole blood samples.
Kunicka J; Malin M; Zelmanovic D; Katzenberg M; Canfield W; Shapiro P; Mohandas N
Am J Clin Pathol; 2001 Dec; 116(6):913-9. PubMed ID: 11764082
[TBL] [Abstract][Full Text] [Related]
26. Health status of transgenic pigs expressing the human complement regulatory protein CD59.
Deppenmeier S; Bock O; Mengel M; Niemann H; Kues W; Lemme E; Wirth D; Wonigeit K; Kreipe H
Xenotransplantation; 2006 Jul; 13(4):345-56. PubMed ID: 16768728
[TBL] [Abstract][Full Text] [Related]
27. Transgenic farm animals: present and future.
Niemann H; Kues W; Carnwath JW
Rev Sci Tech; 2005 Apr; 24(1):285-98. PubMed ID: 16110896
[TBL] [Abstract][Full Text] [Related]
28. Vasoactive properties of synthetic blood substitutes.
de Figueiredo LF
Medicina (B Aires); 1998; 58(4):403-10. PubMed ID: 9816703
[TBL] [Abstract][Full Text] [Related]
29. [Contributions and prospects of hemoglobin derivatives].
Remy B; Deby-Dupont G; Lamy M
Schweiz Med Wochenschr; 1997 Jun; 127(25):1088-96. PubMed ID: 9312831
[TBL] [Abstract][Full Text] [Related]
30. [Preparation of a modified hemoglobin solution of low viscosity used as a blood substitute].
Clerc Y; Dubos M; Brasseur C; Gondran F; Gond B; Delamourd L; Goyffon M; Saint-Blancard J
Ann Pharm Fr; 1987; 45(1):15-23. PubMed ID: 3662338
[No Abstract] [Full Text] [Related]
31. Improved blood substitute: evaluation of its effects on human endothelial cells.
Simoni J; Simoni G; Martinez-Zaguilan R; Wesson DE; Lox CD; Prien SD; Kumar RV
ASAIO J; 1998; 44(5):M356-67. PubMed ID: 9804452
[TBL] [Abstract][Full Text] [Related]
32. Survival of adult islet grafts from transgenic pigs with N-acetylglucosaminyltransferase-III (GnT-III) in cynomolgus monkeys.
Komoda H; Miyagawa S; Omori T; Takahagi Y; Murakami H; Shigehisa T; Ito T; Matsuda H; Shirakura R
Xenotransplantation; 2005 May; 12(3):209-16. PubMed ID: 15807771
[TBL] [Abstract][Full Text] [Related]
33. Cytolytic assessment of hyperacute rejection and production of nuclear transfer embryos using hCD46-transgenic porcine embryonic germ cells.
Won JY; Ahn KS; Sorrell AM; Shin S; Heo SY; Kang JH; Park JK; Chang WK; Shim H
Zygote; 2009 May; 17(2):101-8. PubMed ID: 19063773
[TBL] [Abstract][Full Text] [Related]
34. Production of transgenic cloned piglets from genetically transformed fetal fibroblasts selected by green fluorescent protein.
Lee GS; Kim HS; Hyun SH; Lee SH; Jeon HY; Nam DH; Jeong YW; Kim S; Kim JH; Han JY; Ahn C; Kang SK; Lee BC; Hwang WS
Theriogenology; 2005 Mar; 63(4):973-91. PubMed ID: 15710186
[TBL] [Abstract][Full Text] [Related]
35. Production and characterization of the recombinant human mu-opioid receptor from transgenic silkworms.
Tateno M; Toyooka M; Shikano Y; Takeda S; Kuwabara N; Sezutsu H; Tamura T
J Biochem; 2009 Jan; 145(1):37-42. PubMed ID: 18984628
[TBL] [Abstract][Full Text] [Related]
36. Bovine polymerized hemoglobin (hemoglobin-based oxygen carrier-201) resuscitation in three swine models of hemorrhagic shock with militarily relevant delayed evacuation--effects on histopathology and organ function.
Johnson T; Arnaud F; Dong F; Philbin N; Rice J; Asher L; Arrisueno M; Warndorf M; Gurney J; McGwin G; Kaplan L; Flournoy WS; Apple FS; Pearce LB; Ahlers S; McCarron R; Freilich D
Crit Care Med; 2006 May; 34(5):1464-74. PubMed ID: 16540964
[TBL] [Abstract][Full Text] [Related]
37. Why the omega-3 piggy should go to market.
Kang JX; Leaf A
Nat Biotechnol; 2007 May; 25(5):505-6; author reply 506. PubMed ID: 17483827
[No Abstract] [Full Text] [Related]
38. [Study of polymerizing hemoglobin on cation exchange chromatography].
Wang X; Huang L; Yang C; Wang J
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Oct; 25(5):1146-9. PubMed ID: 19024464
[TBL] [Abstract][Full Text] [Related]
39. Conceptual design and cost estimate for a modified hemoglobin production plant.
Jin CK; Owings D
Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):463-70. PubMed ID: 1391465
[TBL] [Abstract][Full Text] [Related]
40. Genetically Engineered Pigs to Study Cancer.
Kalla D; Kind A; Schnieke A
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31940967
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
